Literature DB >> 21965103

Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology.

Julia Hasslacher, Georg F Lehner, Michael Joannidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21965103     DOI： 10.1007/s00134-011-2384-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  7 in total

1.  Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.

Authors:  Laura Pucci; Stefano Triscornia; Daniela Lucchesi; Carmen Fotino; Giovanni Pellegrini; Ennia Pardini; Roberto Miccoli; Stefano Del Prato; Giuseppe Penno
Journal:  Clin Chem       Date:  2007-01-26       Impact factor: 8.327

Review 2.  Normotensive ischemic acute renal failure.

Authors:  J Gary Abuelo
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

3.  Cystatin C in critically ill patients treated with continuous venovenous hemofiltration.

Authors:  Marije C Baas; Catherine S C Bouman; Frans J Hoek; Raymond T Krediet; Marcus J Schultz
Journal:  Hemodial Int       Date:  2006-10       Impact factor: 1.812

4.  Discrepancy between cystatin C and creatinine points leading to a diagnosis of postrenal acute kidney injury and its reversibility: three case reports.

Authors:  Nao Fujisawa; Masatomo Yashiro; Hiroyoshi Segawa; Yuko Kadoya; Tadashi Kamata
Journal:  Clin Exp Nephrol       Date:  2010-07-06       Impact factor: 2.801

5.  Early detection of acute renal failure by serum cystatin C.

Authors:  Stefan Herget-Rosenthal; Günter Marggraf; Johannes Hüsing; Frauke Göring; Frank Pietruck; Onno Janssen; Thomas Philipp; Andreas Kribben
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

6.  Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy.

Authors:  Hidetoshi Tsuda; Yoshitaka Isaka; Shiro Takahara; Masaru Horio
Journal:  Clin Exp Nephrol       Date:  2009-06-18       Impact factor: 2.801

7.  Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

Authors:  Annick A N M Royakkers; Johanna C Korevaar; Jeroen D E van Suijlen; Lieuwe S Hofstra; Michael A Kuiper; Peter E Spronk; Marcus J Schultz; Catherine S C Bouman
Journal:  Intensive Care Med       Date:  2010-12-10       Impact factor: 17.440
  7 in total
  4 in total

Review 1.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

2.  Comparison of different equations to assess glomerular filtration in critically ill patients.

Authors:  Mieke Carlier; Alexander Dumoulin; Alexander Janssen; Sven Picavet; Steve Vanthuyne; Ria Van Eynde; Raymond Vanholder; Joris Delanghe; Gert De Schoenmakere; Jan J De Waele; Eric A J Hoste
Journal:  Intensive Care Med       Date:  2015-01-27       Impact factor: 17.440

3.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440

4.  Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury.

Authors:  Salih İnal; Atila Altuntaş; Veysel Kidir; Alper Özorak; Yusuf İlgin; Mehmet Tugrul Sezer
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.